Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in: European Surgery 4/2018

25.05.2018 | review

A comprehensive study of the mesopancreas as an extension of the pancreatic circumferential resection margin

verfasst von: Charlotte Maplanka, MSc, PGDip, BSc (Hons)

Erschienen in: European Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Summary

Background and objectives

Data on required excisions to achieve clear margins in pancreatic cancer are conflicting. Similarly, there are inconsistent protocols on aggressive lymphadenectomy. We review retropancreatic tissues, common metastatic lymph nodes and the mesopancreas with respect to pancreatic resection margins to improve our understanding of major sites for relapse that can be specifically targeted for effective treatments.

Materials and methods

This work is two-fold: keywords/phrases identified relevant publications on the mesopancreas and lymphadenectomy in PubMed databases; RCTs, original studies, prospective and retrospective studies were reviewed and results analysed.

Results

Retropancreatic tissues including the mesopancreas are major sites for incomplete resections and relapse. Nomenclature for the mesopancreas is moot; nonetheless, its contents form a network of a neurolymphovascular-rich microenvironment that furnishes pathways for invasion and metastasis. The “mesopancreas” is a rectangular prism-shaped, primary micrometastasis site that overlaps with pancreatic resection margins and common metastatic lymph nodes. Most common infiltrated lymph nodes in 599 patients were stations 13, 17, 14, 12, 8, 16 and 6. Extended lymphadenectomy offers no survival benefit but promotes accurate staging.

Conclusion

A better understanding of the relationship between the anatomical position of the mesopancreas, common metastatic lymph nodes and the pancreatic circumferential resection margin offers important future applications for targeted treatment approaches to control tumour spread, stage nodal disease and reduce disease burden in retropancreatic tissues, frequently infiltrated lymph nodes and other anatomically complex sites such as the superior mesenteric neurovascular pedicle. Excision of common metastatic lymph node stations can improve outcomes.
Vorheriger Artikel A life for surgery: Julius Kraft-Kinz
Nächster Artikel • Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected
Literatur
1.
Peparini N, Chirletti P. Mesopancreas: a boundless structure, namely R1 risk in pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol. 2013;39:1303–8.CrossRefPubMed
2.
Petrou A, Soonawalla Z, Silva M‑A, Manzelli DM, Tabet P‑P, Friend P. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: a retrospective multivariate analysis of a single centre experience. J BUON. 2016;21(4):874–82.PubMed
3.
Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T. Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol. 2007;5:44.CrossRefPubMedPubMedCentral
4.
Bouassida M, Mighri MM, Chtourou MF, Sassi S, Touinsi H, Hajji H, Sassi S. Retroportal lamina or mesopancreas? Lessons learned by anatomical and histological study of thirty three cadaveric dissections. Int J Surg. 2013;11:834–6.CrossRefPubMed
5.
Kawabata Y, Tanaka T, Nishi T, Monma H, Yano S, Tajima Y. Appraisal of total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol. 2012;38:574–9.CrossRefPubMed
6.
Zou H‑D, Tang W, Zhang X‑M, Zhao Q‑H, Xiao B. CT and MR imaging patterns for pancreatic carcinoma invading the extrapancreatic neural plexus (Part II): Imaging of pancreatic carcinoma nerve invasion. World J Radiol. 2012;4(1):13–20.CrossRef
7.
Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in cancer. Nat Rev Cancer. 2011;11:695–707.CrossRefPubMed
8.
Agrawal MK, Thakur DS, Somashekar U, Chandrakar SK, Sharma D. Mesopancreas: myth or reality. J Pancreas. 2010;11(3):230–3.
9.
Mazzeo S, Cappelli C, Battaglia V, Caramella D, Caproni G, Contillo BP, et al. Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. Abdom Imaging. 2010;35:465–70.CrossRefPubMed
10.
Wang X, Zhang H, Wang T, Lau WY, Wang X, Sun J, et al. The concept of retroperitoneal nerve dissection in pancreatic head carcinoma (Review). Int J Oncol. 2015;47(6):2017–27.CrossRefPubMed
11.
Rollandi L‑P, Ordu DA, Piccazzo R, Biscaldi E, Filauro M, Kroencke TJ, et al. Local radiological staging of the cephalic ductal pancreatic adenocarcinoma: resectability criteria and evaluation of the retroportal lamina. A pictorial essay The Electronic Presentation Online System, European Society of Radiology. ECR 2016/C-0449. 2015. https://​doi.​org/​10.​1594/​ecr2016/​C-0449.CrossRef
12.
13.
Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg. 2012;99:1027–35.CrossRefPubMed
14.
Dumitrascu T, Popescu I. Posterior approach pancreaticoduodenectomy: does it really improve long-term survival in pancreatic head cancer. J Pancreas. 2011;12(5):491–2.
15.
Nakagawara H, Tajima H, Miyashita T, Kitagawa H, Makino I, Sakai S, et al. Lymph node spread of gallbladder cancer from the perspective of embryologically-based anatomy and significance of the lymphatic basin along the embryonic right hepatic artery. Mol Clin Oncol. 2014;2:963–7.CrossRefPubMedPubMedCentral
16.
Aimoto T, Mizutani S, Kawano Y, Matsushita A, Yamashita N, Suzuki H, et al. Left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma. J Nippon Med Sch. 2013;80(6):438–45.CrossRefPubMed
17.
Mochizuki K, Gabata T, Kozaka K, Hattori Y, Zen Y, Kitagawa H, Kayahara M, Ohta T, Matsui O. MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy. Eur Radiol. 2010;20(7):1757–67.CrossRefPubMed
18.
Shen X‑H. Perineural invasion in pancreatic cancer: advanced research in the neuro-cancer interactions. Clin Oncol Cancer Res. 2010;7:337–41.CrossRef
19.
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer. Cancer. 2009;115:3379–91.CrossRefPubMed
20.
Cao Z, Xu J, Shao Q, Zhang T, Zhao Y. Surgical treatment of pancreatic head cancer: concept revolutions and arguments. Chin J Cancer Res. 2015;27(4):392–6.PubMedPubMedCentral
21.
Pallisera A, Morales R, Ramia JM. Tricks and tips in pancreatoduodenectomy. World J Gastroenterol. 2014;6(9):344–50.
22.
23.
Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2—randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–68.CrossRefPubMedPubMedCentral
24.
Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, Foster M, Sargent DJ, Pancreas Cancer Working Group. A prospective randomised trial comparing standard pancreaticoduodenectomy with extended pancreaticoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–30.CrossRefPubMed
25.
Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H. Systemic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007;94:265–73.CrossRef
26.
Orci LA, Meyer J, Combescure C, Bühler L, Berney T, Morei P, et al. A Meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma. HPB. 2015;17:565–72.CrossRefPubMedPubMedCentral
27.
Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, et al. Standard versus lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas. J Hepatobiliary Pancreat Sci. 2012;19(3):230–41.CrossRefPubMed
28.
Pedrazzoli S. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging. Cancer Treat Rev. 2015;41(7):577–87.CrossRefPubMed
29.
Jang JY, Kang MJ, Heo JS, Choi SO, Choi DW, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg. 2014;259:656–64.CrossRefPubMed
30.
Dumitrascu T, David L, Popescu I. Posterior versus standard approach pancreaticoduodenectomy: a case-match study. Langenbecks Arch Surg. 2010;395(6):677–84.CrossRefPubMed
31.
Peparini N, Caronna R, Chirletti P. The “meso” of the rectum and the “meso” of the pancreas: similar terms but distinct concepts in surgical oncology. Hepatobiliary-Pancreatic Dis Int. 2015;14(5):548–51.CrossRef
32.
33.
Kostov D, Kobakov G, Yankov D. Mesopancreas excision for pancreatic head adenocarcinoma. Surg Chron. 2016;21(3):117–21.
34.
Mesopancreas PN. A boundless structure, namely the rationale for dissection of the pancreatic area in pancreaticoduodenectomy for pancreatic head carcinoma. World J Gastroenterol. 2015;21(10):2865–70.CrossRef
35.
Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H, et al. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg. 2010;395(4):451–8.CrossRefPubMed
36.
Chowdappa R, Challa VR. Mesopancreas in pancreatic cancer: where do we stand—review of literature. Indian J Surg Oncol. 2015;6(1):69–74.CrossRefPubMed
37.
Kanhere HA, Trochsler MI, Maddern GJ. The “mesopancreas” dissection—a new surgical paradigm: an anatomical “reflection” of surgical and prognostic importance? J Pancreas. 2015;16(5):514–6.
38.
Xu J, Tian X, Chen Y, Ma Y, Liu C, Tian L, et al. Total mesopancreas excision for the treatment of pancreatic head cancer. J Cancer. 2017;8:3575–84.CrossRefPubMedPubMedCentral
39.
Kurosaki I, Minagawa M, Takano K, Takizawa K, Hatakeyama K. Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head. J Pancreas. 2011;12(3):220–9.
40.
Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, et al. Pancreatoduodenectomy with systematic mesopancreas dissection using supracolic anterior artery-first approach. Ann Surg. 2015;262(6):1092–101.CrossRefPubMed
41.
42.
Lupascu C, Ursulescu C, Danila N, Grigorean V, Tarcoveanu E, Andronic D. Early retropancreatic lamina dissection during pancreaticoduodenectomy: how, when and why? Rev Med Chir Soc Med Nat Iasi. 2013;117(1):137–42.PubMed
43.
Lymphadenectomy study group, Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicentre, prospective, randomised study. Ann Surg. 1998;228(4):508–17.CrossRef
44.
Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW (2008) Most Pancreatic Cancer Resections are R1 Resections. Ann Surg Oncol 15(6):1651–1660CrossRefPubMed
45.
Kostov D. Chapter 3: Lymphadenectomy in pancreatic cancer surgery. In: Recent advances in pancreatic cancer. 1st ed. Avid Science 2016. 2016. pp. 1–33.
46.
Ignjatovic I, Knezevic S, Knezevic D, Dugalic V, Micev M, Matic S, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma. J BUON. 2017;22(1):232–8.PubMed
47.
Capussotti L, Massucco P, Ribero D, Viganò L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer. Arch Surg. 2003;138:1316–22.CrossRefPubMed
48.
Tol JAMG, Gouma DJ, Bassi C, et al. Definition of standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the international study group on pancreatic surgery. J Surg. 2014;156(3):591–600Y.
49.
Elshaer M, Gravante G, Kosmin M, Al-Bahrani A. A systemic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma. Ann R Coll Surg Engl. 2017;99:101–6Y.CrossRefPubMedPubMedCentral
50.
Sun W, Leong CH, Zhang Z, Lu JJ. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence. Radiat Oncol. 2010;5(28):2–13.
51.
52.
Coppola R, Borzomati D, Valeri S and Coppola A (2010) Rationale and surgical technique of lymphadenectomy associated with duodenopancreatectomy for pancreatic head carcinoma. In: Asbun HJ, Fuchshuber PR (eds) ACS multimedia atlas of surgery: Pancreas surgery volume, American College of Surgeons, Chicago, available from, https://​cine-med.​com/​?​id=​ACSV2-25
53.
Sharma JS, Gananadha S, Hugh T. Surgical management of carcinoma of the head of pancreas: extended lymphadenectomy or modified en bloc resection? Anz J Surg. 2008;78:228–36.CrossRef
54.
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77.CrossRefPubMed
55.
56.
Makino I, Kitagawa H, Ohta T, Nakagawara H, Tajima H, Ohnishi I, Takamura H, Tani T, Kayahara M. Nerve plexus invasion in pancreatic cancer spread patterns on histopathologic and embryological analyses. Pancreas. 2008;37(4):358–65.CrossRefPubMed
57.
Tamm EP, Fleming JB, Varadhachary GR. Chapter 11: pancreatic ductal adenocarcinoma. In: Oncologic imaging: a multidisciplinary approach: expert consult by Paul M. Silverman. Vol. 11. Amsterdam: Elsevier; 2012. pp. 153–71. ISBN 978-1455733330.CrossRef
58.
Demir IE, Ceyhan GO, Liebi F, D’Haese JG, Maak M, Friess H. Neural invasion in pancreatic cancer: the past, present and future. Cancers (Basel). 2010;2:1513–27.CrossRef
59.
Maplanka C. Gallbladder Cancer, treatment failure and relapses: the peritoneum in gallbladder cancer. J Gastrointest Cancer. 2014;45(3):245–55.CrossRefPubMed
Metadaten
Titel
A comprehensive study of the mesopancreas as an extension of the pancreatic circumferential resection margin
verfasst von
Charlotte Maplanka, MSc, PGDip, BSc (Hons)
Publikationsdatum
25.05.2018
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2018
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-018-0535-z

Weitere Artikel der Ausgabe 4/2018

European Surgery 4/2018 Zur Ausgabe

short communication

Mechanisms of dyspnoea in giant hiatus hernia: an indication to perform surgery?

editorial

Surgery, myth, and delight between seasons

book review

New understanding of GERD and Barrett’s esophagus: histopathology-based disease management

original article

Impact of anatomical versus non-anatomical resection for stage II and III colon cancer

obituary

A life for surgery: Julius Kraft-Kinz

original article

Should surgical ex vivo lymphadenectomy be a standard procedure in the management of patients with gastric cancer?